First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
Titel:
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
Auteur:
Balar, Arjun V Castellano, Daniel O'Donnell, Peter H Grivas, Petros Vuky, Jacqueline Powles, Thomas Plimack, Elizabeth R Hahn, Noah M de Wit, Ronald Pang, Lei Savage, Mary J Perini, Rodolfo F Keefe, Stephen M Bajorin, Dean Bellmunt, Joaquim